The Patent Finder

Arqule, Inc.

Also on record
Records under this name other than the patents Arqule, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 55 patents it holds.

Back to Arqule, Inc.

PatentTitleStatus Expires Confidence
US 9,642,847Combinational compositions and methods for treatment of cancer
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,829,5601,4-disubstituted naphthalenes as inhibitors of P38 MAP kinase
Term ended
Term ended Apr 10, 2026 · From the USPTO record
Term endedTerm ended Apr 10, 2026From the USPTO record
US 9,447,088Compositions and methods for treatment of cancer
Term ended
Term ended Apr 6, 2026 · From the USPTO record
Term endedTerm ended Apr 6, 2026From the USPTO record
US 8,754,078Compositions and methods for treatment of cancer
Term ended
Ended no later than Feb 9, 2026 · From the USPTO record
Term endedEnded no later than Feb 9, 2026From the USPTO record
US 8,114,8731,4-disubstituted naphthalenes as inhibitors of p38 map kinase
Term ended
Term ended Jul 8, 2025 · From the USPTO record
Term endedTerm ended Jul 8, 2025From the USPTO record
US 10,766,868Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine
Lapsed on the fee record
Ended Sep 8, 2024 · From the USPTO record
Lapsed on the fee recordEnded Sep 8, 2024From the USPTO record
US 10,717,710Solid forms of substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds
Lapsed on the fee record
Ended Jul 21, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jul 21, 2024From the USPTO record
US 7,307,0791,3,5-Triazine derivatives as ligands for human adenosine-A3 receptors
Formerly held
Term ended
Term ended Nov 2, 2023 · From the USPTO record
Term endedTerm ended Nov 2, 2023From the USPTO record
US 6,770,6491-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them
Term ended
Term ended Sep 19, 2022 · From the USPTO record
Term endedTerm ended Sep 19, 2022From the USPTO record
US 7,074,824Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
Term ended
Term ended Jun 27, 2022 · From the USPTO record
Term endedTerm ended Jun 27, 2022From the USPTO record
10 of 55 patents shown.
Pro members see all 55.
Pro members: see all 55 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited